Compare LNTH & EMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LNTH | EMAT |
|---|---|---|
| Founded | 1956 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.7B |
| IPO Year | 2014 | N/A |
| Metric | LNTH | EMAT |
|---|---|---|
| Price | $95.42 | $9.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $87.00 | $30.00 |
| AVG Volume (30 Days) | ★ 765.0K | 106.2K |
| Earning Date | 05-07-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | ★ $343,374,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.19 | $2,122.43 |
| P/E Ratio | $53.29 | ★ N/A |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $47.27 | $5.50 |
| 52 Week High | $95.98 | $17.50 |
| Indicator | LNTH | EMAT |
|---|---|---|
| Relative Strength Index (RSI) | 75.76 | 59.63 |
| Support Level | $72.35 | $6.61 |
| Resistance Level | N/A | $10.44 |
| Average True Range (ATR) | 2.94 | 0.80 |
| MACD | 0.96 | 0.01 |
| Stochastic Oscillator | 96.97 | 57.52 |
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Evolution Metals & Technologies Corp is a critical materials and technology company. The company is focused on developing a secure, dependable, and self-sustaining U.S.-aligned supply chain for critical minerals and materials (CMM), and rare earth elements (REEs). The company is also engaged in recycling end-of-life materials through urban mining to help strengthen domestic resource independence and long-term supply stability.